Douglas W Losordo - From the Feinberg Cardiovascular Research Institute, Northwestern University

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 435 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction

Timothy D Henry,C Noel Bairey Merz,Janet Wei,Michel T Corban,Odayme Quesada,Sandy Joung,Christine L Kotynski,Jian Wang,Michelle Lewis,Ann M Schumacher,Ronnda L Bartel,Hiroshi Takagi, Vishal Shah, Anna Lee,William K Sietsema,Douglas W Losordo,Amir Lerman

Circulation. Cardiovascular interventions（2022）

Cited12Views0WOSBibtex

Honedra? (clbs12) autologous cd34+cells improve outcomes in patients with buerger's disease

A. Kawamoto, Y. Furukawa, Y. Fujita, S. Kobayashi,K. Tobita, J. Yamaguchi,W. Shimizu, G. Takagi, H. Matsumura, N. Murata,M. Nakamura,I. Kitano,H. Yokoi, N. Azuma, A. Kozuki, H. Obara, M. Furukawa,W. K. Sietsema,H. Takagi,J. Wang, R. Bartel,D. W. Losordo

CYTOTHERAPY（2021）

Cited0Views0Bibtex

Design of a Confirmatory Pivotal Study with Intramyocardial GCSF-mobilized Autologous CD34 Cells (CLBS14) for the Treatment of an Orphan-Sized Population with No-Option Refractory Disabling Angina

T. Povsic,W. K. Sietsema,J. Wang,H. Takagi,C. Kotynski,D. W. Losordo

Cytotherapy（2020）

Cited1Views0Bibtex

Design of a Potentially Registrational Study of Sakigake-Designated GCSF-Mobilized Autologous CD34 Cell (CLBS12) Therapy of No-Option Critical Limb Ischemia Including Arteriosclerosis Obliterans and Buerger's Disease

A. Kawamoto,Y. Fujita,W. K. Sietsema,J. Wang,H. Takagi,D. W. Losordo

CYTOTHERAPY（2020）

Cited1Views0Bibtex

Abstract 14741: Autologous Cd34+ Cells (clbs119) for Repair of Covid-19 Induced Microvascular Lung Damage: Rationale and Study Design

Douglas W. Losordo,Christine Kotynski,Ronnda Bartel, Hiroshi Takagi,Jian Wang,Michelle Lewis,William K. Sietsema,Daniel Sterman, Alan Harris

Circulation（2020）

Cited0Views0Bibtex

CD34+ Cell Therapy Significantly Reduces Adverse Cardiac Events, Health Care Expenditures, and Mortality in Patients with Refractory Angina

Grace L. Johnson,Timothy D. Henry,Thomas J. Povsic,Douglas W. Losordo,Ross F. Garberich,Larissa Stanberry,Craig E. Strauss,Jay H. Traverse

Stem cells translational medicine（2020）

Cited14Views0WOSBibtex

Autologous CD34+ Cell Therapy for Ischemic Tissue Repair

William K Sietsema,Atsuhiko Kawamoto,Hiroshi Takagi,Douglas W Losordo

Circulation journal official journal of the Japanese Circulation Society（2019）

Cited17Views0WOSBibtex

Significant Reduction in Mortality Following Single Administration of Autologous CD34 Cells in the Orphan Indication of No-Option Refractory Disabling Angina (NORDA): Re-analysis of the Largest Completed Study of CD34 Cell Therapy

Timothy D. Henry,Thomas J. Povsic,William K. Sietsema,Robert M. Clare,Douglas W. Losordo

2019 Scientific Sessions (2019)

Cited0Views0Bibtex

Abstract 15864: Clinical Trial of Autologous CD34 Cell Therapy for Treatment of Coronary Microvascular Dysfunction in Patients with Angina and Non-Obstructive Coronary Arteries

C. Noel Bairey Merz,Timothy D. Henry,Janet Wei,Michel T. Corban,Sandy Joung,Christine Kotynski,Michelle Lewis,Ann M. Schumacher,Ronnda L. Bartel,William K. Sietsema,Douglas W. Losordo,Amir Lerman

Circulation (2019)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn